Skip to main navigation
  • Our Company
    • About Us
    • Executive Team
    • Board of Directors
    • Scientific and Clinical Advisors
    • Partners
  • Our Science
    • Overview
    • CD6-ALCAM Pathway
    • Itolizumab
    • Publications & Presentations
  • Pipeline
    • Overview
    • Pipeline Graphic
    • Clinical Trials
  • Patients
    • Therapeutic Areas
      • Graft-Versus-Host Disease
      • Uncontrolled Moderate to Severe Asthma
      • SLE / Lupus Nephritis
    • Clinical Trials
      • The EQUATE study
      • The EQUIP study
      • The EQUALISE study
  • Investors
    • Investor Overview
    • Stock Quote & Chart
    • Historical Price Lookup
    • News
    • Events & Presentations
    • Analyst Coverage
    • SEC Filings
    • Governance Highlights
    • Committee Composition
    • Investor FAQ
    • Alerts & Contacts
  • Careers
  • Contact Us
    Equillium Bio
    • Our Company
      • About Us
      • Executive Team
      • Board of Directors
      • Scientific and Clinical Advisors
      • Partners
    • Our Science
      • Overview
      • CD6-ALCAM Pathway
      • Itolizumab
      • Publications & Presentations
    • Pipeline
      • Overview
      • Pipeline Graphic
      • Clinical Trials
    • Patients
      • Therapeutic Areas
        • Graft-Versus-Host Disease
        • Uncontrolled Moderate to Severe Asthma
        • SLE / Lupus Nephritis
      • Clinical Trials
        • The EQUATE study
        • The EQUIP study
        • The EQUALISE study
    • Investors
      • Investor Overview
      • Stock Quote & Chart
      • Historical Price Lookup
      • News
      • Events & Presentations
      • Analyst Coverage
      • SEC Filings
      • Governance Highlights
      • Committee Composition
      • Investor FAQ
      • Alerts & Contacts
    • Careers
    • Contact Us

    Committee Composition

    Investor Relations

    • Investor Overview
    • Stock Quote & Chart
    • Historical Price Lookup
    • News
    • Events & Presentations
    • Analyst Coverage
    • SEC Filings
    • Governance Highlights
    • Committee Composition
    • Investor FAQ
    • Alerts & Contacts

    Committee Composition

    Audit Committee Compensation Committee Nominating and Corporate Governance Committee
    Martha J. Demski Audit Committee Compensation Committee
    Bala S. Manian, Ph.D. Audit Committee Compensation Committee
    Charles McDermott Audit Committee Nominating and Corporate Governance Committee
    Mark Pruzanski, M.D. Nominating and Corporate Governance Committee
    = Chairperson = Member = Financial Expert
    2021 © Equillium, Inc. EDPO Certification | Privacy Notice
    Scroll to top